Stereotaxis (STXS) Other Non Operating Income (2010 - 2026)

Stereotaxis' (STXS) quarterly Other Non Operating Income came in at -$5000.0 in Q1 2026, down 266.67% on a QoQ basis from $3000.0 in Q3 2025.

Stereotaxis (STXS) Other Non Operating Income (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 14 years of Other Non Operating Income data on file, last reported at -$5000.0 in Q1 2026.

  • On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$5000.0 in Q1 2026; TTM through Mar 2026 was -$3000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2000.0, changed N/A from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$5000.0, down from $3000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for STXS reached as high as $27000.0 in Q2 2023 and fell as low as -$5000.0 in Q1 2026.
  • Historically, Other Non Operating Income has averaged $4142.9 across 4 years, with a median of $3000.0 in 2023.
  • Across the five-year window, Other Non Operating Income sank 111.11% in 2024 and surged 66.67% in 2025, its largest moves.
  • Year by year, Other Non Operating Income stood at $3000.0 in 2023, then surged by 66.67% to $5000.0 in 2024, then sank by 40.0% to $3000.0 in 2025, then plunged by 266.67% to -$5000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$5000.0 in Q1 2026, $3000.0 in Q3 2025, and -$1000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,000.00
Sep 30, 2025 3,000.00
Jun 30, 2025 -1,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 -3,000.00
Dec 31, 2023 3,000.00
Jun 30, 2023 27,000.00
Sep 30, 2021 -17,000.00
Mar 31, 2018 2.59 Mn
Dec 31, 2017 1.24 Mn
Sep 30, 2017 -4.46 Mn
Jun 30, 2017 300,255.00
Mar 31, 2017 3.13 Mn
Sep 30, 2016 5.47 Mn
Jun 30, 2016 135,370.00
Mar 31, 2016 31,294.00
Dec 31, 2015 507,909.00
Sep 30, 2015 725,356.00
Jun 30, 2015 999,169.00
Mar 31, 2015 -892,377.00